February 14, 2022 / 21:39 IST
Reported Standalone quarterly numbers for Vivimed Labs are:Net Sales at Rs 51.90 crore in December 2021 down 16.87% from Rs. 62.44 crore in December 2020.
Story continues below Advertisement
Quarterly Net Loss at Rs. 23.63 crore in December 2021 down 11687.4% from Rs. 0.20 crore in December 2020.
EBITDA stands negative at Rs. 7.83 crore in December 2021 down 151.24% from Rs. 15.28 crore in December 2020.
Vivimed Labs shares closed at 20.70 on February 11, 2022 (NSE) and has given -8.41% returns over the last 6 months and 41.30% over the last 12 months.
| Vivimed Labs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'21 | Sep'21 | Dec'20 | | Net Sales/Income from operations | 51.90 | 51.04 | 62.44 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 51.90 | 51.04 | 62.44 | | EXPENDITURE | | Consumption of Raw Materials | 38.22 | 39.98 | 33.75 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.49 | -1.37 | -4.42 | | Power & Fuel | -- | -- | -- | | Employees Cost | 8.07 | 7.59 | 9.24 | | Depreciation | 4.27 | 4.17 | 3.95 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 12.60 | 15.73 | 10.15 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -11.74 | -15.05 | 9.76 | | Other Income | -0.36 | 0.14 | 1.57 | | P/L Before Int., Excpt. Items & Tax | -12.10 | -14.91 | 11.33 | | Interest | 11.53 | 8.55 | 11.13 | | P/L Before Exceptional Items & Tax | -23.63 | -23.46 | 0.20 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -23.63 | -23.46 | 0.20 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -23.63 | -23.46 | 0.20 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -23.63 | -23.46 | 0.20 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.85 | -3.07 | 0.02 | | Diluted EPS | -2.77 | -2.98 | 0.02 | | EPS After Extra Ordinary | | Basic EPS | -2.85 | -3.07 | 0.02 | | Diluted EPS | -2.77 | -2.98 | 0.02 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
